Evidence map›Paper›PMID 39559901›Full record

ArticleEpilepsia2025

Automatic responsiveness testing in epilepsy with wearable technology: The ARTiE Watch.

Lydia Wheeler, Vaclav Kremen, Cole Mersereau, Guillermo Ornelas, Taruna Yadav, Devon Cormier, Allyson Derry, Andrea Duque Lopez, Kevin McQuown, Vladimir Sladky and 5 more

Abstract read
In one paragraph

Article in Epilepsia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lydia WheelerDepartment of Neurology, Bioelectronics Neurophysiology, and Engineering Lab, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-3627-1964
Vaclav KremenDepartment of Neurology, Bioelectronics Neurophysiology, and Engineering Lab, Mayo Clinic, Rochester, Minnesota, USA.
Cole MersereauDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Guillermo OrnelasDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Taruna YadavDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Devon CormierDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Allyson DerryDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Andrea Duque LopezDepartment of Neurology, Bioelectronics Neurophysiology, and Engineering Lab, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0009-0009-7102-2024
Kevin McQuownWindy City Labs, Chicago, Illinois, USA.
Vladimir SladkyDepartment of Neurology, Bioelectronics Neurophysiology, and Engineering Lab, Mayo Clinic, Rochester, Minnesota, USA.
Christopher BenjaminDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-2000-9016
Joseph GiacinoDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA.
Gregory WorrellDepartment of Neurology, Bioelectronics Neurophysiology, and Engineering Lab, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-2916-0553
Hal BlumenfeldDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-0812-8132
START Project Collaborative Team

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Thalamic stimulation to prevent impaired consciousness in epilepsyUH3NS112826 · NINDS · YALE UNIVERSITY · PI BLUMENFELD, HAL · 2021 to 2023
$5.4M
Thalamic stimulation to prevent impaired consciousness in epilepsyUG3NS112826 · NINDS · YALE UNIVERSITY · PI BLUMENFELD, HAL · 2019 to 2020
$1.9M
NCATS NIH HHS UL1 TR001863NIH HHS UG3/UH3 NS112826NINDS NIH HHS UG3 NS112826NINDS NIH HHS UH3 NS112826
6 · The paper itself

Abstract

objectiveAn accurate evaluation of behavioral responsiveness during and after seizures in people with epilepsy is critical for diagnosis and management. Current methods for assessing behavioral responsiveness are characterized by substantial variation, subjectivity, and limited reliability and reproducibility in ambulatory and epilepsy monitoring unit settings. In this study, we aimed to develop and implement a novel mobile platform for deployment of automated responsiveness testing in epilepsy-the ARTiE Watch-to facilitate standardized, objective assessments of behavioral responsiveness during and after seizures.

methodsWe prospectively recruited patients admitted to the epilepsy monitoring units for diagnostic evaluation and long-term video-electroencephalographic monitoring at Mayo Clinic and Yale New Haven Hospital. Participants wore the ARTiE Watch, a smartwatch paired with custom smartphone software integrated with cloud infrastructure allowing for remote activation of standardized assessment on the participants' smartwatches. The assessment consisted of 18 command prompts that test behavioral responsiveness across motor, language, and memory domains. Upon visually identifying an electrographic seizure during EMU monitoring, the BrainRISE platform was used to deploy the ARTiE Watch behavioral testing sequence. Responsiveness scoring was conducted on smartwatch files.

resultsEighteen of 56 participants had a total of 39 electrographic seizures assessed with the ARTiE Watch. The 18 subjects with ARTiE Watch-tested seizures had a total of 67 baseline (interictal) ARTiE Watch tests collected for analysis. The analysis showed distinct ARTiE Watch behavioral responsiveness phenotypes: (1) decreased responsiveness across all ARTiE Watch commands during seizure (ictal-postictal) periods compared (to baseline (p < .0001), (2) decreased responsiveness in bilateral tonic-clonic seizures compared to baseline (p < .0001) and compared to focal seizures (p < .0001), and (3) decreased responsiveness during focal impaired awareness seizures compared to baseline (p < .0001) and compared to focal aware seizures (p < .001). SIGNIFICANCE: ARTiE Watch behavioral testing deployed utilizing a mobile cloud-based platform is feasible and can provide standardized, objective behavioral responsiveness assessments during seizures.

Indexed as

EpilepsyWearable Electronic DevicesAdolescentAdultElectroencephalographyFemaleHumansMaleMiddle AgedProspective StudiesReproducibility of ResultsSeizuresSmartphoneYoung Adultattentionbehavioral testingconsciousnessfocal seizuregeneralized seizurememorysafetysemiologywearable technology

Identifiers

PMID39559901
PMCPMC11817799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.